Advertisement Promega opens new biological products facility in China   - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Promega opens new biological products facility in China  

Promega Corporation has opened a new facility, Shanghai Promega Life Science Center in China.

The new facility for Shanghai Promega Biological Products will replace present molecular biology reagent production site and also provide additional research, development and cGMP manufacturing capabilities for molecular diagnostics products for the Chinese market.

The building, which is equipped for the manufacture of molecular biology and molecular diagnostic reagents, is expected to begin production in the next few weeks.

Promega CEO Bill Linton said China is an integral part of Promega’s manufacturing and business operations.

"This recent investment in the new Shanghai cGMP manufacturing facility represents Promega’s continued commitment to life science in China," Linton added.

The new facility is one of five Promega manufacturing sites across the globe.